Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1994;8 Suppl 1:53-7.
doi: 10.1111/j.1365-2036.1994.tb00253.x.

A Review of Treatment of Duodenal and Gastric Ulcers--Pantoprazole vs. Omeprazole

Affiliations
Review

A Review of Treatment of Duodenal and Gastric Ulcers--Pantoprazole vs. Omeprazole

W Schepp et al. Aliment Pharmacol Ther. .

Abstract

The efficacy and safety of pantoprazole in the treatment of duodenal and gastric ulcers has been compared with that of the first proton pump inhibitor omeprazole in two (previously reported) clinical studies. Pantoprazole (40 mg/day) administered orally was an effective and well-tolerated treatment for both indications. Pantoprazole was as effective as omeprazole (20 mg/day) and had a similar safety profile. For gastric ulcers, the healing rate with pantoprazole was superior to that with omeprazole at 4 weeks.

Similar articles

See all similar articles

Cited by 2 articles

MeSH terms

LinkOut - more resources

Feedback